• Revenue increased by 21% to $7.06 million
• Adjusted net loss decreased by 7% to $32.9 million
• Gross margins exceeded 90%
• No dividends declared
• Audit of financial statements in process

4DMedical Ltd announced its preliminary final report for the year ended 30 June 2026. The company reported a 21% increase in revenue to $7.06 million, with gross margins exceeding 90%. The adjusted net loss decreased by 7% to $32.9 million compared to the previous year. The company recognized a non-cash expense of $164.6 million relating to the fair value measurement of the equity component of the Pro Medicus Loan. No dividends have been paid or declared since the end of the previous financial year, and the directors do not recommend the declaration of a dividend. The financial statements are in the process of being audited.

Adjusted net loss for FY26 down 7% to $32.9 million

The company is focused on its commercial momentum and strategic initiatives to drive future growth.